News Merck KGaA to develop immunotherapies with F-star German Merck has option to licence LAG3-PDL1 drug.
News FDA to review Novartis CAR-T next month If all goes well, FDA could approve CTL109 by late September
News ASCO round up: Zytiga shines in frontline prostate role, Lox... While ASCO often showcases the benefits of new cancer therapies, it was a well-established drug that proved to be a talking point at this year’s conference in Chicago.
Views & Analysis Digital health round-up: consumer wearables are lagging There's a lot more to do before consumer wearables can truly make an impact.
Views & Analysis Taking up the gauntlet A review of Cancer Research UK's Grand Challenge awards programme for the latest cancer research projects.
News Major UK market breakthrough for Keytruda in lung cancer But funding will last only two years on CDF.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
